Showing BioInteractions for Hyaluronidase (human recombinant) (DB06205)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting Group | Interacting Drugs | |
---|---|---|
Hyaluronidase (human recombinant) is a Hyaluronic acid modulator | ||
1 | Hyaluronic acid modulators | Hyaluronidase |
2 | Hyaluronic acid metabolizers | Hyaluronidase |
Interacting Group | Interacting Drugs | |
---|---|---|
Hyaluronidase (human recombinant) is a Hyaluronic acid metabolizer | ||
1 | Hyaluronic acid modulators | Hyaluronidase |
2 | Hyaluronic acid metabolizers | Hyaluronidase |
Interacting Group | Interacting Drugs | |
---|---|---|
Hyaluronidase (human recombinant) is a Transforming growth factor beta-1 inhibitor | ||
1 | Transforming growth factor beta-1 inhibitors | Hyaluronidase, Hyaluronidase (ovine) |
2 | Transforming growth factor beta-1 agonists | Foreskin fibroblast (neonatal), Foreskin keratinocyte (neonatal) |
3 | Transforming growth factor beta-1 inducers | Terazosin |